U.S. federal trademark · Serial No. 99020991
Bio-engineered cells for medical use; preparations of cells, namely, induced pluripotent stem cells (iPSCs), hepatocytes, induced pluripotent stem cell (iPSC)-derived hepatocytes, hepatocyte-like cells, adipose cells, and adipogenic cells in the field of cellular medicine for the treatment of genetic diseases and disorders, genomic diseases and disorders, metabolic disorders, orthopedic conditions, musculoskeletal diseases and disorders, gastrointestinal diseases and disorders, immune system-related diseases and disorders, dermatological diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, cancer, diabetes, and respiratory diseases and disorders; pharmaceutical and therapeutic preparations for the treatment of diseases, namely, genetic diseases and disorders, genomic diseases and disorders, metabolic disorders, orthopedic conditions, musculoskeletal diseases and disorders, gastrointestinal diseases and disorders, immune system-related diseases and disorders, dermatological diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, cancer, diabetes, and respiratory diseases and disorders; implantable therapeutics, namely, DNA vectors being molecules for delivering genetic material into cells and cells used for human gene therapy for medical use
Scientific research, pharmaceutical research, medical research; stem cell research services; technical scientific consultation and product development for others in the field of biotechnology, bioengineering, and the development of pharmaceuticals; pharmaceutical drug development services
Stem cells for research or scientific purposes
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.